2022
DOI: 10.1016/j.copbio.2022.102788
|View full text |Cite
|
Sign up to set email alerts
|

Progress toward rapid, at-line N-glycosylation detection and control for recombinant protein expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

2
3

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 57 publications
0
6
0
Order By: Relevance
“…Harvested IgG was purified with a 96‐well protein A plate (Thermofisher) as described previously. [ 100 ] The plate was pre‐equilibrated by washing three times with PBS followed by centrifuging at 300 x g for 2 min. Then, clarified cell culture media was added to each well and incubated for 5–10 min.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Harvested IgG was purified with a 96‐well protein A plate (Thermofisher) as described previously. [ 100 ] The plate was pre‐equilibrated by washing three times with PBS followed by centrifuging at 300 x g for 2 min. Then, clarified cell culture media was added to each well and incubated for 5–10 min.…”
Section: Methodsmentioning
confidence: 99%
“…Quantification was described as previously reported by gating cells with positive staining as compared to the control (unsupplemented) condition. [ 100 ]…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Glycoproteins produced in CHO cells resemble those produced in the native human body due to a lack of α‐galactose residues, making clinical transferability considerably more efficient. Despite their widespread use, the ability to measure and control post‐translational modifications during a bioprocess remains limited 4,5 …”
Section: Introductionmentioning
confidence: 99%
“…Although many tools are available for analyzing glycan microheterogeneity, 4 glycan macroheterogeneity is frequently characterized towards the end of the downstream process by mass spectrometry (MS), which requires expert knowledge and is time intensive. Thus, a simpler and faster screening platform that allows characterization of both glycan micro‐ and macroheterogeneity is needed; such a rapid analysis platform will be essential for screening process conditions that affect antibody quality.…”
Section: Introductionmentioning
confidence: 99%